Key facts
- NewDays’s last known valuation is $27.0M (Oct 2025).
- It has raised $11.5M across 1 recorded rounds; the latest was Early Stage VC ($8.5M) in Sep 2025.
- Notable investors include General Catalyst, Madrona Venture Group, View Different, Highbury Group, WS Investments.
- NewDays has filed 2 Form Ds with the SEC since 2025, most recently Jun 2026 ($8.5M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for NewDays
Funding rounds
1 roundsAbout NewDays
Developer of AI-based healthcare tools designed to improve cognitive health. The company's services include regular telehealth appointments, personalized brain exercise homework, and deep clinical research, enabling people living with mild cognitive impairment and dementia to get quality treatment.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2024
- Employees
- 24
- Website
- newdays.ai/
- Ownership
- Privately Held (backing)
NewDays doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NewDays shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NewDays in its N-PORT filings yet. We sweep new filings monthly.